ASPIRIN PROPHYLAXIS IN MIGRAINE

B. P. O'Neill; J. D. Mann

doi:10.1016/S0140-6736(78)92159-1

ASPIRIN PROPHYLAXIS IN MIGRAINE

B. P. O'Neill, J. D. Mann

Neurology

Research output: Contribution to journal › Article › peer-review

63 Scopus citations

Abstract

A prospective double-blind trial of aspirin prophylaxis demonstrated a reduction of more than 50% in headache frequency in 9 of 12 migraine patients. Response to aspirin did not correlate with age, duration of headache history, family history, or platelet ultrastructure. There is some evidence that response to aspirin is associated with raised platelet aggregation. This pilot study indicates that aspirin is effective in migraine prophylaxis.

Original language	English (US)
Pages (from-to)	1179-1181
Number of pages	3
Journal	The Lancet
Volume	312
Issue number	8101
DOIs	https://doi.org/10.1016/S0140-6736(78)92159-1
State	Published - Dec 2 1978

ASJC Scopus subject areas

General Medicine

Access to Document

10.1016/S0140-6736(78)92159-1

Cite this

@article{d597c7f661104c44b5cccdcc68a4279d,

title = "ASPIRIN PROPHYLAXIS IN MIGRAINE",

abstract = "A prospective double-blind trial of aspirin prophylaxis demonstrated a reduction of more than 50% in headache frequency in 9 of 12 migraine patients. Response to aspirin did not correlate with age, duration of headache history, family history, or platelet ultrastructure. There is some evidence that response to aspirin is associated with raised platelet aggregation. This pilot study indicates that aspirin is effective in migraine prophylaxis.",

author = "O'Neill, {B. P.} and Mann, {J. D.}",

year = "1978",

month = dec,

day = "2",

doi = "10.1016/S0140-6736(78)92159-1",

language = "English (US)",

volume = "312",

pages = "1179--1181",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "8101",

}

TY - JOUR

T1 - ASPIRIN PROPHYLAXIS IN MIGRAINE

AU - O'Neill, B. P.

AU - Mann, J. D.

PY - 1978/12/2

Y1 - 1978/12/2

N2 - A prospective double-blind trial of aspirin prophylaxis demonstrated a reduction of more than 50% in headache frequency in 9 of 12 migraine patients. Response to aspirin did not correlate with age, duration of headache history, family history, or platelet ultrastructure. There is some evidence that response to aspirin is associated with raised platelet aggregation. This pilot study indicates that aspirin is effective in migraine prophylaxis.

AB - A prospective double-blind trial of aspirin prophylaxis demonstrated a reduction of more than 50% in headache frequency in 9 of 12 migraine patients. Response to aspirin did not correlate with age, duration of headache history, family history, or platelet ultrastructure. There is some evidence that response to aspirin is associated with raised platelet aggregation. This pilot study indicates that aspirin is effective in migraine prophylaxis.

UR - http://www.scopus.com/inward/record.url?scp=0018171852&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018171852&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(78)92159-1

DO - 10.1016/S0140-6736(78)92159-1

M3 - Article

C2 - 82144

AN - SCOPUS:0018171852

SN - 0140-6736

VL - 312

SP - 1179

EP - 1181

JO - The Lancet

JF - The Lancet

IS - 8101

ER -

ASPIRIN PROPHYLAXIS IN MIGRAINE

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this